Atoltivimab
Atoltivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
Link from a Wikipage to another Wikipage
primaryTopic
Atoltivimab
Atoltivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
has abstract
Atoltivimab is a Zaire ebolavi ...... aire ebolavirus (Ebola virus).
@en
CAS number
2135632-29-8
class
FDA UNII code
FJZ07Q63VY
KEGG
Link from a Wikipage to an external page
Wikipage page ID
65,587,388
page length (characters) of wiki page
Wikipage revision ID
1,011,364,848
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
class
DailyMedID
Atoltivimab
@en
KEGG
D11468
@en
mab type
mab
@en
pregnancy US
N
@en
pronounce
a" tol tiv' i mab
@en
source
u
@en
target
Zaire ebolavirus glycoprotein
@en
type
mab
@en
UNII
FJZ07Q63VY
@en
wikiPageUsesTemplate
subject
comment
Atoltivimab is a Zaire ebolavi ...... aire ebolavirus (Ebola virus).
@en
label
Atoltivimab
@en